Vnitr Lek 2019, 65(7-8):468-469 | DOI: 10.36290/vnl.2019.082

Je to sepse, nebo není? A je presepsin tou správnou odpovědí? - editorial

Martin Matějovič
I. interní klinika LF UK a FN Plzeň

Received: June 10, 2019; Published: July 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Matějovič M. Je to sepse, nebo není? A je presepsin tou správnou odpovědí? - editorial. Vnitr Lek. 2019;65(7-8):468-469. doi: 10.36290/vnl.2019.082.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Goto T, Yoshida K, Tsugawa Y et al. Infectious Disease-Related Emergency Department Visits of Elderly Adults in the United States, 2011-2012. J Am Geriatr Soc 2016; 64(1): 31-36. Dostupné z DOI: <http://dx.doi.org/10.1111/jgs.13836>. Go to original source... Go to PubMed...
    2. Fleischmann C, Scherag A, Adhikari NK et al. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. Am J Respir Crit Care Med 2016; 193(3): 259-272. Dostupné z DOI: <http://dx.doi.org/10.1164/rccm.201504-0781OC>. Go to original source... Go to PubMed...
    3. Filbin MR, Lynch J, Gillingham TD et al. Presenting Symptoms Independently Predict Mortality in Septic Shock: Importance of a Previously Unmeasured Confounder. Crit Care Med 2018; 46(10): 1592-1599. Dostupné z DOI: <http://dx.doi.org/10.1097/CCM.0000000000003260>. Go to original source... Go to PubMed...
    4. Kaukonen KM, Bailey M, Pilcher D et al. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med 2015; 372(17): 1629-1638. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1415236>. Go to original source... Go to PubMed...
    5. Heffner AC, Horton JM, Marchick MR et al. Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department. Clin Infect Dis 2010; 50(6): 814-820. Dostupné z DOI: <http://dx.doi.org/10.1086/650580>. Go to original source... Go to PubMed...
    6. Káňová M, Dobiáš R, Liszková K et al. Presepsin v diagnostice sepse. Vnitř lék 2019; 65(7-8): 497-505. Go to original source... Go to PubMed...
    7. Jabor A, Kubíček Z, Labanczová M et al. Presepsin: co je nutné vědět pro korektní interpretaci. Vnitř lék 2019; 65(7-8): 490-496. Go to original source... Go to PubMed...
    8. Qi Z, Zhang Q, Liu B et al. Presepsin As a Biomarker for Evaluating Prognosis and Early Innate Immune Response of Out-of-Hospital Cardiac Arrest Patients After Return of Spontaneous Circulation. Crit Care Med 2019; 47(7): e538-e546. Dostupné z DOI: <http://dx.doi.org/10.1097/CCM.0000000000003764>. Go to original source... Go to PubMed...
    9. Kondo Y, Umemura Y, Hayashida K et al. Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis. J Intensive Care 2019; 7: 22. Dostupné z DOI: <http://dx.doi.org/10.1186/s40560-019-0374-4>. Go to original source... Go to PubMed...
    10. Scicluna BP, van Vught LA, Zwinderman AH et al. MARS consortium. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. Lancet Respir Med 2017; 5(10): 816-826. Dostupné z DOI: <http://dx.doi.org/10.1016/S2213-2600(17)30294-1>. Go to original source... Go to PubMed...
    11. Seymour CW, Kennedy JN, Wang S et al. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA 2019. Dostupné z DOI: <http://dx.doi.org/10.1001/jama.2019.5791>. Go to original source... Go to PubMed...
    12. Horák J, Harazim M, Karvunidis T et al. Sepse - jak ji poznat, na co se zaměřit aneb zpět k základům ve světle nové definice. Vnitř Lék 2016; 62(7-8): 568-574. Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.